192 related articles for article (PubMed ID: 31500625)
1. Biofluid quantification of TWEAK/Fn14 axis in combination with a selected biomarker panel improves assessment of prostate cancer aggressiveness.
Ruiz-Plazas X; Rodríguez-Gallego E; Alves M; Altuna-Coy A; Lozano-Bartolomé J; Portero-Otin M; García-Fontgivell JF; Martínez-González S; Segarra J; Chacón MR
J Transl Med; 2019 Sep; 17(1):307. PubMed ID: 31500625
[TBL] [Abstract][Full Text] [Related]
2. TWEAK activation of the non-canonical NF-κB signaling pathway differentially regulates melanoma and prostate cancer cell invasion.
Armstrong CL; Galisteo R; Brown SA; Winkles JA
Oncotarget; 2016 Dec; 7(49):81474-81492. PubMed ID: 27821799
[TBL] [Abstract][Full Text] [Related]
3. The TNF-like weak inducer of the apoptosis/fibroblast growth factor-inducible molecule 14 axis mediates histamine and platelet-activating factor-induced subcutaneous vascular leakage and anaphylactic shock.
Mendez-Barbero N; Yuste-Montalvo A; Nuñez-Borque E; Jensen BM; Gutiérrez-Muñoz C; Tome-Amat J; Garrido-Arandia M; Díaz-Perales A; Ballesteros-Martinez C; Laguna JJ; Beitia JM; Poulsen LK; Cuesta-Herranz J; Blanco-Colio LM; Esteban V
J Allergy Clin Immunol; 2020 Feb; 145(2):583-596.e6. PubMed ID: 31679818
[TBL] [Abstract][Full Text] [Related]
4. Role of the tumour necrosis factor-like weak inducer of apoptosis (TWEAK)/fibroblast growth factor-inducible 14 (Fn14) axis in autoimmune thyroid disease.
Peng S; Yu X; Zhao X; Wang X; Sun X; Han C; Shan Z; Li C; Teng W
Clin Endocrinol (Oxf); 2017 Dec; 87(6):783-790. PubMed ID: 28636775
[TBL] [Abstract][Full Text] [Related]
5. [Prediction Value of TWEAK/Fn14 in Crohn's Disease with Intestinal Fibrosis].
Xu T; Yang Y; Zhao L; Zhou DD; Zhang Y
Sichuan Da Xue Xue Bao Yi Xue Ban; 2017 Sep; 48(5):721-726. PubMed ID: 29130664
[TBL] [Abstract][Full Text] [Related]
6. Differential expression of the TWEAK receptor Fn14 in IDH1 wild-type and mutant gliomas.
Hersh DS; Peng S; Dancy JG; Galisteo R; Eschbacher JM; Castellani RJ; Heath JE; Legesse T; Kim AJ; Woodworth GF; Tran NL; Winkles JA
J Neurooncol; 2018 Jun; 138(2):241-250. PubMed ID: 29453678
[TBL] [Abstract][Full Text] [Related]
7. [Expression of TWEAK/Fn14 in Pancreatic Cancer].
Wei AL; Guo Q; Gong S
Sichuan Da Xue Xue Bao Yi Xue Ban; 2017 Jan; 48(1):154-157. PubMed ID: 28612578
[TBL] [Abstract][Full Text] [Related]
8. Use of two gene panels for prostate cancer diagnosis and patient risk stratification.
Xiao K; Guo J; Zhang X; Feng X; Zhang H; Cheng Z; Johnson H; Persson JL; Chen L
Tumour Biol; 2016 Aug; 37(8):10115-22. PubMed ID: 26820133
[TBL] [Abstract][Full Text] [Related]
9. TWEAK/Fn14 Activation Participates in Skin Inflammation.
Liu Q; Xiao S; Xia Y
Mediators Inflamm; 2017; 2017():6746870. PubMed ID: 29038621
[TBL] [Abstract][Full Text] [Related]
10. A major role of TWEAK/Fn14 axis as a therapeutic target for post-angioplasty restenosis.
Méndez-Barbero N; Gutierrez-Muñoz C; Madrigal-Matute J; Mínguez P; Egido J; Michel JB; Martín-Ventura JL; Esteban V; Blanco-Colio LM
EBioMedicine; 2019 Aug; 46():274-289. PubMed ID: 31395500
[TBL] [Abstract][Full Text] [Related]
11. Improving the Rotterdam European Randomized Study of Screening for Prostate Cancer Risk Calculator for Initial Prostate Biopsy by Incorporating the 2014 International Society of Urological Pathology Gleason Grading and Cribriform growth.
Roobol MJ; Verbeek JFM; van der Kwast T; Kümmerlin IP; Kweldam CF; van Leenders GJLH
Eur Urol; 2017 Jul; 72(1):45-51. PubMed ID: 28162815
[TBL] [Abstract][Full Text] [Related]
12. PSA enzymatic activity: a new biomarker for assessing prostate cancer aggressiveness.
Ahrens MJ; Bertin PA; Vonesh EF; Meade TJ; Catalona WJ; Georganopoulou D
Prostate; 2013 Dec; 73(16):1731-7. PubMed ID: 23934862
[TBL] [Abstract][Full Text] [Related]
13. TWEAK/Fn14 interaction induces proliferation and migration in human airway smooth muscle cells via activating the NF-κB pathway.
Zhu C; Zhang L; Liu Z; Li C; Bai Y
J Cell Biochem; 2018 Apr; 119(4):3528-3536. PubMed ID: 29143982
[TBL] [Abstract][Full Text] [Related]
14. TWEAK/Fn14 mediates atrial-derived HL-1 myocytes hypertrophy via JAK2/STAT3 signalling pathway.
Hao L; Ren M; Rong B; Xie F; Lin MJ; Zhao YC; Yue X; Han WQ; Zhong JQ
J Cell Mol Med; 2018 Sep; 22(9):4344-4353. PubMed ID: 29971943
[TBL] [Abstract][Full Text] [Related]
15. Zinc α2-glycoprotein as a potential novel urine biomarker for the early diagnosis of prostate cancer.
Katafigiotis I; Tyritzis SI; Stravodimos KG; Alamanis C; Pavlakis K; Vlahou A; Makridakis M; Katafigioti A; Garbis SD; Constantinides CA
BJU Int; 2012 Dec; 110(11 Pt B):E688-93. PubMed ID: 23020913
[TBL] [Abstract][Full Text] [Related]
16. Out of the TWEAKlight: Elucidating the Role of Fn14 and TWEAK in Acute Kidney Injury.
Sanz AB; Ruiz-Andres O; Sanchez-Niño MD; Ruiz-Ortega M; Ramos AM; Ortiz A
Semin Nephrol; 2016 May; 36(3):189-98. PubMed ID: 27339384
[TBL] [Abstract][Full Text] [Related]
17. TWEAK-Fn14 as a common pathway in the heart and the kidneys in cardiorenal syndrome.
Poveda J; Vázquez-Sánchez S; Sanz AB; Ortiz A; Ruilope LM; Ruiz-Hurtado G
J Pathol; 2021 May; 254(1):5-19. PubMed ID: 33512736
[TBL] [Abstract][Full Text] [Related]
18. Disruption of the TWEAK/Fn14 pathway prevents 5-fluorouracil-induced diarrhea in mice.
Sezaki T; Hirata Y; Hagiwara T; Kawamura YI; Okamura T; Takanashi R; Nakano K; Tamura-Nakano M; Burkly LC; Dohi T
World J Gastroenterol; 2017 Apr; 23(13):2294-2307. PubMed ID: 28428709
[TBL] [Abstract][Full Text] [Related]
19. Characterization of RNA-Binding Motif 3 (RBM3) Protein Levels and Nuclear Architecture Changes in Aggressive and Recurrent Prostate Cancer.
Carleton NM; Zhu G; Miller MC; Davis C; Kulkarni P; Veltri RW
Cancer Rep (Hoboken); 2020 Jun; 3(3):e1237. PubMed ID: 32587951
[TBL] [Abstract][Full Text] [Related]
20. TWEAK/Fn14 promotes oxidative stress through AMPK/PGC‑1α/MnSOD signaling pathway in endothelial cells.
Liu H; Peng H; Xiang H; Guo L; Chen R; Zhao S; Chen W; Chen P; Lu H; Chen S
Mol Med Rep; 2018 Jan; 17(1):1998-2004. PubMed ID: 29257217
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
